Thomas W. Beetham, EVP & Chief Legal Officer at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 4,954 shares at $22.09 ($109K) on 2021-02-03, disclosed to the SEC on 2021-02-05.
Open-market sale of $109k KNSA by EVP & Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.09 | 2,477 | $55K | 50.0% |
| 2 | $22.09 | 2,477 | $55K | 50.0% |
| Total | $22.09 avg | 4,954 | $109K | 100% |
| Filing → |
| KNSA | SELL | 2020-07-02 | $1.5M | — | Filing → |
| KNSA | SELL | 2020-06-12 | $690K | — | Filing → |
| KNSA | SELL | 2020-04-22 | $1.9M | — | Filing → |